Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
The Global Nuclear Medicine Market to Exhibit Growth at a Significant CAGR of ~10% by 2027 | DelveInsight | ||||||||||||||||||||||||||||||||||||||
By: PR Newswire Association LLC. - 30 Mar 2023 | Back to overview list |
|||||||||||||||||||||||||||||||||||||
The nuclear medicine market is expanding rapidly due to the rising prevalence of cancer, cardiovascular disease, and other chronic diseases caused by an inactive lifestyle. Furthermore, the growing geriatric population susceptible to chronic diseases, rising demand for image-guided procedures and diagnostics globally, and the presence of robust products in the pipeline will drive nuclear medicine demand during the forecast period LAS VEGAS, March 30, 2023 /PRNewswire/ -- DelveInsight's Nuclear Medicine Market Insights report provides the current and forecast market analysis, individual leading nuclear medicine companies' market shares, challenges, nuclear medicine market drivers, barriers, and trends, and key nuclear medicine companies in the market. Key Takeaways from the Nuclear Medicine Market Report
To read more about the latest highlights related to the nuclear medicine market, get a snapshot of the key highlights entailed in the Global Nuclear Medicine Market Report Nuclear Medicine Overview Nuclear Medicine is an essential component of today's healthcare delivery system and has a significant impact on patient care. The development of various radionuclide and radio-labeled compounds and equipment has resulted in rapid growth in the Nuclear Medicine Market over the last four to five decades. Nuclear medicine employs trace amounts of radioactive materials (or tracers) in products and procedures to aid in the diagnosis and treatment of a wide range of illnesses. Iodine-131 was the first radionuclide used in medicine. Following that, several other radionuclides and isotopes were created for diagnostic purposes. Several radioisotopes are now produced and distributed in the market for various medical purposes. The two major types of conditions for which Nuclear Medicine has enormous potential are cancer and cardiovascular disease. It also has applications in a variety of diseases, including nephro-urology, orthopedics, rheumatology, and neuropsychiatry. Nuclear Medicine Market Insights North America dominated the global nuclear medicine market in 2021 and will continue to do so during the forecast period (2022–2027). This can be attributed to the region's increasing incidence of cancer, cardiovascular disorders, and other diseases due to high processed food consumption and lifestyle changes. Furthermore, the presence of key domicile players in the region, the rising burden of the geriatric population prone to chronic diseases, the favorable reimbursement scenario for radiopharmaceuticals in the United States, and others are among the key factors that contribute to the growth of the nuclear medicine market in North America between 2022 and 2027. In addition, the rise in product launches in the region is expected to boost the nuclear medicine market growth. For instance, in April 2022, the FDA recently approved 177Lu-PSMA-617 (Lu 177 vipivotide tetraxetan; Pluvicto) as a targeted radioligand therapy for the treatment of patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC). To know more about why North America is leading the market growth in the nuclear medicine market, get a snapshot of the Nuclear Medicine Market Outlook Nuclear Medicine Market Dynamics One of the key factors driving the nuclear medicine market is the rising prevalence of cancer, cardiovascular disease, and other diseases around the world, which can be attributed to a variety of factors such as genetics, age, obesity, and unhealthy lifestyles. Furthermore, the establishment of nuclear medicine centers that will provide access to nuclear medicine treatments all over the world is expected to boost the nuclear medicine market. Moreover, increasing technological advancements in disease diagnosis and treatment, and the rising approval of new nuclear medicine-based devices that aid in meeting patients' treatment needs will drive the nuclear medicine market in the coming years. However, the high cost of nuclear medicine, the equipment used in the procedure, and the stringent regulatory approval process may impede the growth of the nuclear medicine market. Additionally, the nuclear medicine market suffered during the COVID-19 pandemic because the outbreak resulted in the cancellation of outpatient visits and the suspension of non-emergency hospitalization and diagnostic procedures. As a result, routine clinical examinations and diagnosis procedures were reduced. However, the development of the COVID-19 vaccine has begun the process of economic recovery, with the easing of lockdown restrictions and the return of normalcy in the economic landscape, which has begun the process of resumption of regular healthcare services such as outpatient visits for diagnosis and treatment purposes, bringing the demand for products in the nuclear medicine market back on track. Get a sneak peek at the nuclear medicine market dynamics @ Nuclear Medicine Market Dynamics Analysis
Nuclear Medicine Market Assessment
Which MedTech key players in the nuclear medicine market are set to emerge as the trendsetter explore @ Nuclear Medicine Companies Table of Contents
Interested in knowing the nuclear medicine market by 2027? Click to get a snapshot of the Nuclear Medicine Market Trends Related Reports Cancer Therapy Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cancer therapy companies, including GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, Sanofi, among others. Oncology Drugs Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key oncology drugs companies, including GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, among others. Cardiac Biomarkers Testing Market Cardiac Biomarkers Testing Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cardiac biomarkers testing companies, including Beckman Coulter, Inc, Siemens Healthcare GmbH, Abbott, among others. Angio Suites Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key angio suites companies, including Siemens, Koninklijke Philips N.V, Lam Vascular and Associates, Hitachi, Ltd., ESAOTE SPA, IMRIS, Onex Corporation, among others. Schizophrenia Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key schizophrenia companies, including Neurocrine Bioscience, Takeda Pharmaceutical Company, Memory Pharmaceuticals, among others. Epilepsy Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key epilepsy companies, including Eisai Co.LTD., Alexza Pharmaceuticals, Xenon Pharmaceuticals, among others. Other Trending Reports Tay-sachs Disease Or Gm2 Gangliosidosis Market | Onycholysis Market | Diagnostic Imaging Equipment Market | Chemotherapy-induced Peripheral Neuropathy Market | Global Electrophysiology Devices Market | Anaphylaxis Market | Atherectomy Devices Market | Helicobacter Pylori Infections Market | Ophthalmic Imaging Equipment Market | Androgenetic Alopecia Market | Allergic Rhinitis Market | Chronic Inflammatory Demyelinating Polyneuropathy Market | Chronic Inflammtory Demyelinating Polyneuropathy Market | Colorectal Cancer Crc Market | Opioid Induced Constipation Market | Vertigo Market | Bone Anchored Hearing Systems Market | Wound Closure Devices Market | Hip Replacement Devices Market | Hemodynamic Monitoring Systems Market | Egfr Non-small Cell Lung Cancer Market | Helicobacter Pylori Infection Market | Hyperkalemia Market | Polycythemia Market Neurostimulation Devices Market | Carpal Tunnel Syndrome Market | Ventilator Market | Cerebral Aneurysm Market | Alpha Antitrypsin Market | Binge Eating Disorder Market | Bunion Market | Concussions Market Size | Exocrine Pancreatic Insufficiency Market | Healthcare Due Diligence Services | Minimal Residual Disease Market | Hypertrophic Scar Market | Lung Fibrosis Market | Anterior Uveitis Market | 22q11.2 deletion syndrome Market | X-Linked Retinitis Pigmentosa (XLRP) Market | Acute Radiation Syndrome Market | Alpha-1 Protease Inhibitor Deficiency Market | Androgenetic Alopecia Market | Hyperlipidemia Market | Cardiotoxicity Market | Hypertrophic Cardiomyopathy Market | Fatty Acid Oxidation Disorders (FAODs) Market | Androgen Insensitivity Syndrome Market | Emphysema Market | Canaloplasty Market | Dravet Syndrome Market | Celiac Disease Market | Chlamydia Infections Market | Syphilis Market | Renal Tubular Acidosis Market | Palmoplantar Pustulosis (PPP) Market | Aplastic Anemia Market | Bacterial Pneumonia Market | B cell Chronic Lymphocytic Leukemia Market | B cell Lymphomas Market | Behcets Disease Market Neoantigen-based Personalized Cancer therapeutic Vaccines Competitive Landscape and Market Forecast—by 2035 | Glioblastoma Market Related Healthcare Blogs Upcoming Oncological Drugs in 2022 Metastatic Castration-Sensitive Prostate Cancer Treatment Market Checkpoint Inhibitor Refractory Cancer Market Promising Oncolytic Virues Candidates in Pipeline ENHERTU's Journey in Cancer Treatment and Management Potential of PD-1 and PD-L1 Inhibitors in Cancer Management Evolving EGFR NSCLC Treatment Market Dynamics Emerging Role of Digital Health in the Field of Oncology Upcoming Cardiovascular Diseases Drugs Key Companies in the Cardiology Segment Top Cardiac Devices in the Market Digital Therapeutics for Mental Health Related Cases Studies Related Healthcare Services Healthcare Competitive Intelligence Services Healthcare Asset Prioritization Services About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve. Connect with us on LinkedIn|Facebook|Twitter Additionally, get in touch with our business executive to explore @ Healthcare Due Diligence Services Contact Us Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/the-global-nuclear-medicine-market-to-exhibit-growth-at-a-significant-cagr-of-10-by-2027--delveinsight-301785577.html SOURCE DelveInsight Business Research, LLP |
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Copyright 2023 PR Newswire Association LLC. | Back to overview list |